![Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam](https://www.abcam.com/ps/products/216/ab216574/Images/ab216574-480637-antimet-cmet-antibody-ep1454y--nterminal-western-blot.JPG "Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam")
Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam
Anti-MET Antibody (PACO01060) | WB
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM | PNAS
Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cancer Cell International | Full Text
![Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)](https://www.abcam.com/ps/products/227/ab227637/Images/ab227637-4-AntiMet-cMet-antibody-SP44--Cterminal-IHC-Human-colon-carcinoma.jpg "Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)")
Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)
c-Met Monoclonal Antibody (3D4) (18-7366)
Frontiers | The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth
Met (c Met) Polyclonal Antibody – Bioss
Targeting MET in Lung Cancer: Will Expectations Finally Be MET? - ScienceDirect
![Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)](https://www.abcam.com/ps/products/51/ab51067/Images/ab51067-481633-ab51067-anticmet-hela-002.jpg "Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)")
Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)
![Recombinant Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (ab68141)](https://www.abcam.com/ps/products/68/ab68141/Images/ab68141-82348-anti-met-c-met-phospho-y1349-antibody-ep2367y-immunohistochemistry.jpg?impolicy=product-thumbnail "Recombinant Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (ab68141)")
Recombinant Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (ab68141)
IJMS | Free Full-Text | Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain
Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer - touchONCOLOGY
c-Met (Cytoplasmic) antibody (25869-1-AP) | Proteintech
Met (c Met) Polyclonal Antibody – Bioss
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification | BMC Cancer | Full Text
AACR 2023: YH013, a Novel Bispecific EGFR x MET Antibody-Drug Conjugate, Exhibits Potent Anti-Tumor Efficacy - Biocytogen
Classification of HGF/c-MET Inhibitors. | Download Table
c-Met Polyclonal Antibody (PA5-85951)
Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer - ScienceDirect
They Should Be in Jail': Nan Goldin, Anti-Sackler Opioid Activists Take Fight to Guggenheim, Met – ARTnews.com
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition | Journal of Nuclear Medicine
Anti-c-Met antibody
